Cost Saving
By prescribing Sevodyne® by brand you could save 69% on your
current buprenorphine 7-day transdermal patches prescribing costs.1**
By prescribing Sevodyne by brand, the average savings for a CCG could still be £150,300 per year,2* providing the NHS with a total potential annual prescribing cost saving of approximately £19.8 million.2*
Sevodyne Cost Calculator
To find out how much you could save by prescribing Sevodyne, please follow the instructions on the Sevodyne calculator:
Sevodyne is part of the cost-saving prolonged-release product range from Aspire Pharma.
- 69% saving on UK Drug Tariffs price for buprenorphine transdermal patches1**
- Available from mainline wholesalers
- Pricing not dependent on competitor activity***
- Price guaranteed***
| Product | UK Drug Tariffs price1 | Sevodyne price | NHS Saving when Sevodyne is Prescribed |
|---|---|---|---|
| Buprenorphine transdermal patch 5 microgram/hr x 4 | £17.60 | £5.53 | £12.07 |
| Buprenorphine transdermal patch 10 microgram/hr x 4 | £31.55 | £9.93 | £21.62 |
| Buprenorphine transdermal patch 15 microgram/hr x 4 | £49.15 | £15.48 | £33.67 |
| Buprenorphine transdermal patch 20 microgram/hr x 4 | £57.46 | £18.09 | £39.37 |
*Savings based on market data in reference 2. Savings calculated from 2021 spend of 132 Healthboards/CCGs switching their generic and originator brand 5, 10, 15 and 20mcg buprenorphine transdermal patch prescriptions to Sevodyne. **Based on 69% saving on the cost of buprenorphine transdermal patches in the UK Drug Tariffs. ***No change in price subject to no material change to the products of the UK Drug Tariffs until the 2024 PPRS review.
References: 1) November 2021 UK Drug Tariffs. 2) Insypher Data July 2021 Based on Annual Moving Total (UK)
TRUSTED BRANDS.
DEPENDABLE SUPPLY CHAIN.
For further information please call: 01730 231148,
email: customerservices@aspirepharma.co.uk or visit www.aspirepharma.co.uk
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
For more information about Sevodyne, please see the abbreviated prescribing information.
Revision reference – Sevodyne_11_29.11.2021
